Furthermore, the discriminative capacity of the signature combining serum 6-miRNAs and f(Hb) values was similar when comparing CRC from late stages (III/IV) and CRC from early stages (I/II) versus control subjects (Figure 3A,B). The gene discussed is GSTM1; the disease is colorectal carcinoma.